×
Pulmonx Operating Expenses 2019-2024 | LUNG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pulmonx operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
View More
Pulmonx Operating Expenses 2019-2024 | LUNG
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Pulmonx operating expenses from 2019 to 2024. Operating expenses can be defined as the sum of all operating expenses for the given industry.
Related Stocks
Company Name
Market
Cap
GE HealthCare Technologies (GEHC)
$40.4B
Tempus AI (TEM)
$7.9B
Inspire Medical Systems (INSP)
$6.2B
Axonics (AXNX)
$3.5B
Hims & Hers Health (HIMS)
$3.5B
10x Genomics (TXG)
$2.7B
Enovis (ENOV)
$2.4B
Azenta (AZTA)
$2.4B
Privia Health (PRVA)
$2.3B
IRhythm Technologies (IRTC)
$2.2B
Omnicell (OMCL)
$2B
Clover Health Investments (CLOV)
$1.5B
Schrodinger (SDGR)
$1.4B
Phreesia (PHR)
$1.4B
Standard BioTools (LAB)
$753M
Fulgent Genetics (FLGT)
$694M
Definitive Healthcare (DH)
$538M
Health Catalyst (HCAT)
$529M
Butterfly Network (BFLY)
$406M
Talkspace (TALK)
$343M
SOPHiA GENETICS SA (SOPH)
$286M
TruBridge (TBRG)
$183M
P3 Health Partners (PIII)
$165M
American Well (AMWL)
$147M
Augmedix (AUGX)
$115M
EUDA Health Holdings (EUDA)
$90M
Future Health ESG (FHLT)
$65M
SHL Telemedicine (SHLT)
$55M
HeartBeam (BEAT)
$53M
111 (YI)
$51M